Related Experiment Video

Updated: Jun 27, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Tetracyclines may be therapeutically beneficial in rheumatoid arthritis

R A Greenwald1

  • 1Long Island Jewish Medical Center/Albert Einstein College of Medicine/School of Medicine and School of Dental Medicine, State University of New York at Stony Brook.

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|December 17, 2008
PubMed

Insights

Minocycline shows mild anti-inflammatory effects for rheumatoid arthritis (RA). However, tetracyclines may prevent connective tissue degradation, offering a potential breakthrough for treating destructive arthritis.

Area of Science:

  • Rheumatology
  • Pharmacology

Background:

  • Recent clinical trials investigated minocycline for rheumatoid arthritis (RA) with mixed results.
  • Current anti-inflammatory therapies for RA have limitations, and the benefits of minocycline alone may not warrant large-scale trials.

Purpose of the Study:

  • To review the properties of tetracyclines as matrix metalloproteinase inhibitors.
  • To explore the potential of tetracyclines in preventing connective tissue degradation in destructive arthritides.
  • To suggest trial designs for evaluating tetracyclines' unique properties in RA treatment.

Main Methods:

  • Review of basic science and preliminary clinical data on tetracyclines.
  • Analysis of tetracyclines' mechanism as matrix metalloproteinase inhibitors.
  • Conceptualization of clinical trial designs.

Main Results:

  • Tetracyclines, including minocycline, exhibit anti-inflammatory properties.
  • Compelling data suggests tetracyclines may inhibit matrix metalloproteinases, crucial in connective tissue degradation.
  • Preliminary evidence indicates a potential role for tetracyclines in managing destructive arthritides.

Conclusions:

  • Tetracyclines show promise beyond conventional anti-inflammatory effects in RA.
  • Inhibiting matrix metalloproteinases positions tetracyclines as potential disease-modifying agents for arthritis.
  • Further research and specifically designed trials are needed to validate the role of tetracyclines in preventing joint destruction.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...